Last edition
News about "Biologics and Biosimilars "
Kemwell Biopharma’s drug-product manufacturing facility in Bengaluru has received clearance from the US Food and Drug Administration (FDA) for the commercial manufacturing and testing of injectable products intended for the US market, following the successful completion of a pre-approval inspection (PAI).
Biologics And Biosimilars | 29/10/2025 | By Dineshwori
Enzene Integrates Virtuosi to Develop Globally Competitive Pharmaceutical Workforce
With this collaboration, Enzene becomes the first Indian company to partner with Virtuosi —marking a major milestone in building a fully skilled and globally competitive pharmaceutical workforce.
Biologics And Biosimilars | 09/10/2025 | By Dineshwori | 134
The global biologics and biosimilars market is expected to reach approximately USD 600 billion by 2032, expanding at a compound annual growth rate (CAGR) of around 6.33 percent during the forecast period.
Biologics And Biosimilars | 15/07/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy